glp 1 agonist diabetes GLP-1 Agonists - What is it? Could GLP-1 Receptor Agonists Help
Description
Clinical data are also sparse
The FDA states that exenatide, the first GLP-1 receptor agonist, is being phased out as of January 2025 due to a GLP-1 scarcity
In contrast to traditional diuretics that primarily offer symptomatic management, this novel therapeutic agent demonstrates dual breakthroughs in both pathophysiological intervention and prognostic improvement
doi:10.1007/bf00274255 27
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): A 56-week, double-blind, phase 3a, randomised trial
Saxenda highlights of prescribing information
